Based on the molecular expression patterns of BC cells, BC can be divided into three subtypes, with triple-negative breast cancer (TNBC) lacking expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression [3, 4]. Here, ESR1 is linked to triple-negative breast carcinoma.